← Evidence map

ArticleStem cell research & therapy2025

Fine-tuning licensing strategies to boost MSC-based immunomodulatory secretome.

Maria Rossello-Gelabert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40247371